[Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: III. Relation with Type II diabetes: regulation by hepatokines].
Hirofumi
H
Misu
D003924:Diabetes Mellitus, Type 2 / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D007333:Insulin Resistance; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D009389:Neovascularization, Pathologic; D065626:Non-alcoholic Fatty Liver Disease / Q000150:complications* / Q000378:metabolism*; D051149:Selenoprotein P / Q000378:metabolism; D060749:alpha-2-HS-Glycoprotein / Q000378:metabolism
D036341:Intercellular Signaling Peptides and Proteins; C103468:LECT2 protein, human; D051149:Selenoprotein P; D060749:alpha-2-HS-Glycoprotein